REVIEW
Published on 16 Jul 2024
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine
doi 10.3389/fphar.2024.1381476
- 5,348 views
- 3 citations
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- Methods in Gastrointestinal and Hepatic Pharmacology 2023
Methods in Gastrointestinal and Hepatic Pharmacology 2023
5,719
Total downloads
22k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 28 Jun 2024
A novel bioinformatics strategy to uncover the active ingredients and molecular mechanisms of Bai Shao in the treatment of non-alcoholic fatty liver disease
doi 10.3389/fphar.2024.1406188
- 918 views
ORIGINAL RESEARCH
Published on 05 Jun 2024
Quantitative evaluation of the time-course and efficacy of targeted agents for ulcerative colitis
doi 10.3389/fphar.2024.1399963
- 1,057 views
ORIGINAL RESEARCH
Published on 01 May 2024
Phytic acid attenuates acetaminophen-induced hepatotoxicity via modulating iron-mediated oxidative stress and SIRT-1 expression in mice
doi 10.3389/fphar.2024.1384834
- 1,461 views
- 2 citations
ORIGINAL RESEARCH
Published on 01 May 2024
Investigating the L-Glu-NMDA receptor-H2S-NMDA receptor pathway that regulates gastric function in rats’ nucleus ambiguus
doi 10.3389/fphar.2024.1389873
- 743 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Apr 2024
Propranolol can correct prolonged QT intervals in patients with cirrhosis
doi 10.3389/fphar.2024.1370261
- 1,877 views
BRIEF RESEARCH REPORT
Published on 27 Mar 2024
Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
doi 10.3389/fphar.2024.1376656
- 676 views
- 1 citation
REVIEW
Published on 29 Feb 2024
Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications
doi 10.3389/fphar.2024.1354809
- 5,356 views
- 7 citations
ORIGINAL RESEARCH
Published on 23 Feb 2024
Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma
doi 10.3389/fphar.2024.1364924
- 1,405 views
